-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Upgrades Madrigal Pharmaceuticals to Outperform, Announces $605 Price Target

Benzinga·08/04/2026 09:29:54
Listen to the news
Wolfe Research analyst Andy Chen upgrades Madrigal Pharmaceuticals (NASDAQ:MDGL) from Peer Perform to Outperform and announces $605 price target.